about
Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental strokeImaging Reactive Oxygen Species-Induced Modifications in Living Systems.Mouse models in neurological disorders: applications of non-invasive imaging.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.Cell Sheet Transplantation for Esophageal Stricture Prevention after Endoscopic Submucosal Dissection in a Porcine Model.ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection.Methods to monitor gene therapy with molecular imaging.Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease.Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technologyThe translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs).Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor AntagonismMultimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model.Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis.Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI.Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflammation.Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake.Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.Preclinical Evidence That 3'-Deoxy-3'-[18F]Fluorothymidine PET Can Visualize Recovery of Hematopoiesis after Gemcitabine Chemotherapy.Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
P50
Q27321403-4458B140-527E-449D-8CB4-D32FFA76BD11Q30381432-F18CD2B3-5DB6-44D0-B300-731187EE3240Q33578648-22C74EC9-FFFD-45C6-9FF7-CB9DE299B74FQ34203953-D5DFC1BB-4DA1-49F7-81CC-06EA645459B3Q34826426-2765FCAD-3BCA-49EF-9A90-3C84DBEDECDCQ35941066-786896A3-A954-4619-B4F9-709B300EE20CQ36305961-885E83A5-0C2A-44E9-A540-2BDB07F3D6E7Q37422676-D91F9F7F-D614-4A27-A4C3-2EB59162672CQ37570992-83571D58-255C-4602-98C5-1C0FADE88C62Q37995451-C6BA7CBA-695B-4B34-B5CE-2507412F848BQ38786526-65D3D3C0-0E08-4355-9BFA-0399FBF333A5Q38962780-40EC582B-0BE2-4438-A1FF-36BB332B33C7Q39000642-A52DA08E-C6A4-4CBD-AC05-99942A7146BFQ39210624-6DC9D213-6532-43C1-9D2B-B725D9660530Q39407528-E781BD4C-6A5F-493F-8CA0-7CDD8A0DC9BCQ39946792-0408D64D-7503-401D-B5EB-1F2F1C4EE813Q41455445-05E0DAC2-B38A-4B87-A102-ABA5D2B6F863Q41994160-9A402135-7B4B-4A3F-A6E4-ABB58D630AC4Q43196007-50FD536F-0871-4251-B4C1-B5E9DD906279Q45737030-A6EA01C5-F6F0-4633-A3F1-1AC2C78CF7D8Q46066009-93975760-3B03-47D8-A23E-D1D10145621AQ46466432-A5EA127A-8EDD-41E5-8FD2-435BEAB9A9A0Q47881099-ED232FB7-79F2-436A-A22C-8C255C7132C3Q48013213-231C034A-957E-405A-9F19-0CC6E87453CFQ48332788-D6B0913A-4ECD-47F5-8DB0-2187A3DF85EDQ48476268-F489248C-C65A-48DD-AC4C-07EDB9C24F45Q52959153-9C8B7977-4116-4BE5-ABF9-178909AFC63BQ57295258-AFB1BD5D-DD32-49E8-930F-6C6AB387A803
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Viel
@ast
Thomas Viel
@en
Thomas Viel
@es
Thomas Viel
@nl
Thomas Viel
@sl
type
label
Thomas Viel
@ast
Thomas Viel
@en
Thomas Viel
@es
Thomas Viel
@nl
Thomas Viel
@sl
prefLabel
Thomas Viel
@ast
Thomas Viel
@en
Thomas Viel
@es
Thomas Viel
@nl
Thomas Viel
@sl
P106
P1153
57194530952
P21
P31
P496
0000-0002-0756-9166